Georgia is 11th State to Introduce 340B Contract Pharmacy Access Bill in 2025

Georgia state Rep. Todd Jones (R) introduced a bill prohibiting drugmaker 340B contract pharmacy restrictions in the state.
Georgia has become the 11th state to introduce a 340B contract pharmacy bill in the opening weeks of the 2025 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA-backed Conservative Think Tank Suggests DOGE Should Prioritize 340B Reform to Cut Government Costs

ALEC, a drug industry-funded conservative policy group, suggested 340B reform “is a great place to start” in improving government efficiency.
A drug industry-funded conservative policy group suggested that 340B reform “should be a priority” for large scale government cost-cutting efforts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Pushes to Dismiss Health Systems’ Lawsuits Over J&J 340B Audits Amid Uncertainty Under New Trump Admin

HRSA is seeking to dismiss five health systems' lawsuits in the U.S. District Court for the District of Columbia.
The Health Resources and Services Administration (HRSA) has continued to push a federal judge to dismiss five health systems’ lawsuits [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New Colorado Bill Would Prohibit 340B Contract Pharmacy Restrictions, Add Hospital Reporting Rules

Colorado state Senate President Pro Tempore Dafna Michaelson Jenet (D) joined four other lawmakers in co-sponsoring a 340B contract pharmacy access bill with certain hospital reporting provisions.
Five high-ranking Colorado state lawmakers have introduced a bill backed by state hospitals and health centers that would prohibit drugmaker [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri

Key briefs were filed last week in litigation over state contract pharmacy access laws in West Virginia and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NYT Investigation Highlights Federal Law’s Unintended Harm to 340B Providers

A recent New York Times investigation found that part of a COVID-19 relief bill meant to lower drug prices actually increased costs for 340B providers and some of their most vulnerable patients.
A provision in a 2021 COVID-19 relief bill that sought to lower prescription drug prices has actually made some medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Four More States Introduce 340B Contract Pharmacy Access Bills in 2025

Lawmakers in the Hawaii state legislature recently introduced companion 340B contract pharmacy access bills, and legislators in North Dakota, Oregon and Oklahoma also introduced similar bills.
Hawaii, North Dakota, Oklahoma and Oregon have joined the quickly growing list of states to introduce 340B contract pharmacy access [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sanofi Reinstates Contract Pharmacy Restrictions in Kansas, West Virginia Following State Legal Developments

Sanofi will soon begin restricting 340B contract pharmacy use in Kansas and West Virginia after previously exempting providers in those states.
French pharmaceutical giant Sanofi has reinstated its 340B contract pharmacy restrictions in Kansas and West Virginia following legal developments in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Cassidy, Sanders Call for Passing Drug Pricing Bills as Key 340B Committee Holds First Meeting; Kennedy Confirmation Stalls

Senate Health, Education, Labor and Pensions Committee Chairperson U.S. Sen. Bill Cassidy (R-La.) speaks at the panel's first meeting in the 119th Congress on Tuesday.
The Republican and Democratic leaders of the U.S. Senate Health, Energy, Labor and Commerce (HELP) Committee—which has jurisdiction over 340B-related [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal 340B Lobbying Activity Held Steady in Q4 of 2024, Filings Show

More than 350 firms reported lobbying on the 340B program between Oct. 1 and Dec. 31, 2024.
The 340B drug discount program continued to be a hot topic for lobbyists in the final quarter of 2024, keeping [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live